G-BA Approves LDCT Lung Cancer Screening for German Statutory Health Insurance from April 2026

Germany's G-BA confirmed on 13 March 2026 that LDCT lung cancer screening will become a statutory GKV benefit from 1 April 2026 for smokers and ex-smokers aged 50-75 with a 20 pack-year history. The decision translates landmark NELSON and NLST trial evidence into population care and sets a precedent for European HTA agencies still deliberating on programme introduction.